What's New

Tisagenlecleucel (Kymriah ™)

Tisagenlecleucel (Kymriah ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of acute lymphoblastic leukemia. 

Axicabtagene Ciloleucel (Yescarta ™)

Axicabtagene Ciloleucel (Yescarta ™) is a CD19-directed genetically-modified autologous (self-directed) T cell immunotherapy cancer treatment used in the treatment of some types of non-Hodgkin lymphoma.  

Blogs

OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.


Cancer and Its Effect on Kids
by Carolyn Vachani, MSN, RN, AOCN
Jan 18, 2018


The Power of Friendship
by Christina Bach, MSW, LCSW, OSW-C
Jan 17, 2018


View all Blogs

Ringing in the New Year

The New Year is a time to reflect on the past year and look toward the upcoming year. This often inspires people to commit to working towards a healthier lifestyle. Learn about 6 resolutions to reduce cancer risk or starting an exercise regimen. Bob celebrates the New Year with his wishes for people with cancer.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.